198 related articles for article (PubMed ID: 23416630)
1. The Physician Payments Sunshine Act and the unaddressed role of nurses: an interest group analysis.
Grundy Q
Policy Polit Nurs Pract; 2012 Aug; 13(3):154-61. PubMed ID: 23416630
[TBL] [Abstract][Full Text] [Related]
2. The physician payment sunshine act is here--are you ready?
Lazarus JA
J Miss State Med Assoc; 2013 Jun; 54(6):177. PubMed ID: 23991517
[No Abstract] [Full Text] [Related]
3. Sunshine Act update.
W V Med J; 2013; 109(5):40. PubMed ID: 24294711
[No Abstract] [Full Text] [Related]
4. Radiology and industry: can this relationship be saved?
Forman HP
J Am Coll Radiol; 2006 May; 3(5):333-4. PubMed ID: 17412076
[No Abstract] [Full Text] [Related]
5. ACA "Sunshine Act & controlled substance database.
Tenn Med; 2013 Apr; 106(4):11. PubMed ID: 23617033
[No Abstract] [Full Text] [Related]
6. Pharma corruption.
Prescrire Int; 2014 Apr; 23(148):88. PubMed ID: 24860888
[No Abstract] [Full Text] [Related]
7. Physician payment disclosure under health care reform: will the sun shine?
Mackey TK; Liang BA
J Am Board Fam Med; 2013; 26(3):327-31. PubMed ID: 23657702
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceuticals and medical devices: business practices.
Steiner DJ
Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
[No Abstract] [Full Text] [Related]
9. Shining the light on physician-pharmaceutical and medical device industry financial relationships.
Conn L; Vernaglia L
J Vasc Surg; 2011 Sep; 54(3 Suppl):22S-5S. PubMed ID: 21872111
[TBL] [Abstract][Full Text] [Related]
10. Professionalism and physician interactions with industry.
Collins J
J Am Coll Radiol; 2006 May; 3(5):325-32. PubMed ID: 17412075
[TBL] [Abstract][Full Text] [Related]
11. Doctors and drug companies.
Lambert LA
N Engl J Med; 2005 Feb; 352(7):733-4; author reply 733-4. PubMed ID: 15716575
[No Abstract] [Full Text] [Related]
12. Physician payment sunshine act.
Merino JG
BMJ; 2013 Aug; 347():f4828. PubMed ID: 23908473
[No Abstract] [Full Text] [Related]
13. Why self-regulation does not work: resolving prescription corruption caused by excessive gift-giving by pharmaceutical manufacturers.
Mehta RS
Food Drug Law J; 2008; 63(4):799-821. PubMed ID: 19593922
[No Abstract] [Full Text] [Related]
14. French "sunshine act" sheds little light on drug industry's payments to doctors, say critics.
Benkimoun P
BMJ; 2013 Jun; 346():f3762. PubMed ID: 23757751
[No Abstract] [Full Text] [Related]
15. Avoiding over-deterrence in managing physicians' relationships with industry.
Stell LK
Am J Bioeth; 2010 Jan; 10(1):27-9. PubMed ID: 20077334
[No Abstract] [Full Text] [Related]
16. Marketing of antipsychotic drugs targeted doctors of Medicaid patients, report says.
Roehr B
BMJ; 2012 Oct; 345():e6633. PubMed ID: 23033376
[No Abstract] [Full Text] [Related]
17. The devil in the detail(ing).
Morreim H
Am J Bioeth; 2010 Jan; 10(1):15-7. PubMed ID: 20077328
[No Abstract] [Full Text] [Related]
18. The details are in the field.
Schwab AP
Am J Bioeth; 2010 Jan; 10(1):19-21. PubMed ID: 20077330
[No Abstract] [Full Text] [Related]
19. Huddle gets it right, most docs don't.
Rubin PH
Am J Bioeth; 2010 Jan; 10(1):17-9. PubMed ID: 20077329
[No Abstract] [Full Text] [Related]
20. Industry ties in otolaryngology: initial insights from the physician payment sunshine act.
Rathi VK; Samuel AM; Mehra S
Otolaryngol Head Neck Surg; 2015 Jun; 152(6):993-9. PubMed ID: 25779469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]